A Study of Vismodegib With Surgery in Participants With Previously Untreated Basal Cell Carcinoma

Inclusion Criteria:

* Diagnosis of non-infected, not recurrent, previously untreated basal cell carcinoma
* Free of any significant physical abnormalities (e.g., tattoos) at the target basal cell carcinoma site
* Willing and able to participate in the study as an outpatient and agreement to make frequent visits to the clinic during the treatment and follow-up periods and to comply with study requirements

Exclusion Criteria:

* Prior treatment with vismodegib
* Known hypersensitivity to any of the study drug excipients
* Any metastatic basal cell carcinoma
* Any locally advanced basal cell carcinoma considered to be inoperable or to have a medical contraindication to surgery
* Evidence of clinically significant and unstable diseases or conditions (e.g., cardiovascular, immunosuppressive, hematologic)
* Any dermatological disease at the target basal cell carcinoma site that may cause difficulty with examination
* Recent, current, or planned participation in another experimental drug study